Case 15 — Source-review index: unresolved, documented and corrected
Correction note for “Source-review index: unresolved, documented and corrected”: retain the wording beginning “Use clear evidence-status labels and dates, and link…” in the record. If later material changes it, add the date, the changed wording and the source for that change; do not invent a completed correction here. Keep the stated question separate from any broader claim.
Case 16 — Dispatch email versus carrier acceptance: how should the timeline read?
A order log contains a dispatch email on Friday and the first physical acceptance scan on Tuesday. The proposed review currently calls all four days carrier transit. Which events should the timeline distinguish?
Exercise PHARMACY-15754/16: address this question within its stated limits.
Case 16 — Dispatch email versus carrier acceptance: how should the timeline read?
Keep three separate fields: dispatch statement, label creation if recorded, and the first physical acceptance event shown by the carrier. State the timezone of each record; the dispatch email alone does not establish carrier possession.
Case 16 — Dispatch email versus carrier acceptance: how should the timeline read?
Are the event timestamps in the same timezone? Keep the original timestamp and its timezone beside any converted value. Removing the timezone can change which calendar day an event appears to fall on.
Case 16 — Dispatch email versus carrier acceptance: how should the timeline read?
A clear row would read: Friday—dispatch stated in email; Tuesday—carrier acceptance recorded; handover time—not independently established. That gives readers a useful chronology without a claim the records cannot support.
Case 16 — Dispatch email versus carrier acceptance: how should the timeline read?
The acceptance scan is evidence of the recorded acceptance event, but missing earlier scans do not prove exactly when handover occurred. Describe that interval as uncertain rather than asserting a four-day seller delay.
Case 16 — Dispatch email versus carrier acceptance: how should the timeline read?
For a public copy, remove the tracking token, account identifiers and recipient details. Keep the original records privately so a support enquiry can refer to them.
Case 16 — Dispatch email versus carrier acceptance: how should the timeline read?
Update the summary if an earlier custody record becomes available. Preserve the old interpretation in a dated correction rather than rewriting the entire thread without notice.
Case 17 — Packaging evidence: a mismatch is a question, not an authenticity verdict
A documentation exercise has an outer carton date written differently from the inner packaging. No manufacturer confirmation is attached. What should a useful evidence request ask for?
Exercise PHARMACY-15754/17: address this question within its stated limits.
Case 17 — Packaging evidence: a mismatch is a question, not an authenticity verdict
Record the two markings exactly, identify which packaging layer each came from and keep the original photographs privately. Date-format differences alone do not establish the reason for the discrepancy.
Case 17 — Packaging evidence: a mismatch is a question, not an authenticity verdict
Do not infer product contents or safety from typography, seals or a matching batch string. Ask a licensed pharmacist or the manufacturer how the specific presentation should be verified.
Case 17 — Packaging evidence: a mismatch is a question, not an authenticity verdict
Use an evidence-status table: observed marking; source image; explanation requested from; response received; unresolved points. Leave the explanation blank until a verifiable response exists.
Case 17 — Packaging evidence: a mismatch is a question, not an authenticity verdict
Could the public description retain the product-document version and market while removing identifying prescription data? The professional reviewing the originals may need details that do not belong on a public forum.
Case 17 — Packaging evidence: a mismatch is a question, not an authenticity verdict
The closing summary should distinguish the observed discrepancy from any later verified explanation and link the official information that supports the correction.
Case 17 — Packaging evidence: a mismatch is a question, not an authenticity verdict
An ordinary forum review cannot certify a medicine. If the product is uncertain, the useful response is professional verification, not trying it to see whether it appears to work.